Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Osiris Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Osiris Therapeutics Inc market cap is N/A.
What is the 52-week high for Osiris Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Osiris Therapeutics Inc 52 week high is N/A as of September 07, 2025.
What is the 52-week low for Osiris Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Osiris Therapeutics Inc 52 week low is N/A as of September 07, 2025.
What was Osiris Therapeutics Inc stock price yesterday?
Osiris Therapeutics Inc stock price yesterday was $18.99.
What is the PE ratio of Osiris Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Osiris Therapeutics Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Osiris Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Osiris Therapeutics Inc P/B ratio is None.
What is Osiris Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Osiris Therapeutics Inc's EBITDA is N/A.
What is the 50-day moving average of Osiris Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Osiris Therapeutics Inc 50-day moving average is N/A.
How many employess does Osiris Therapeutics Inc has?